Insulin glargine
Once-daily long-acting background insulin.
- Starts working
- 1–2 hours, no peak
- Half-life
- Duration about 24 hours
- In use since
- 2000
- Pregnancy
- Generally considered safe
Overview
Insulin glargine is a long-acting 'basal' insulin that provides a steady background level over about 24 hours. It's used in type 1 diabetes alongside mealtime insulin, and in type 2 when tablets aren't enough.
Conditions it's used for
How it works
Releases slowly from under the skin to keep blood sugar steady all day and night.
Insulin glargine belongs to the Insulins. How Insulins work: let cells take sugar from the blood and tell the liver to stop releasing it.
Uses
- Type 1 diabetes (basal)
- Type 2 diabetes
Available as: pen injection, vial, cartridge.
Typical dose
- Adults
- Individual — commonly started at 10 units (or 0.1–0.2 units/kg) once a day and adjusted to fasting glucose.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Low blood sugar
- Weight gain
- Injection-site lumps
Serious — get medical help
Uncommon, but need prompt attention
- Severe hypoglycaemia
- Low potassium (rare)
Warnings
- Rotate injection sites to avoid fatty lumps
- Never mix with other insulins in the same syringe
- Check strength — U300 and U100 are not interchangeable unit-for-unit
Interactions
- Sulfonylureas — hypos
- Beta blockers — mask hypos
- Steroids — raise sugar
Other medicines in the atlas that need care with Insulin glargine, grouped by the reason:
More risk of low blood sugarMinorWith Glibenclamide, Gliclazide, Glimepiride, Glipizide, Human insulin and 6 more
Both medicines lower blood sugar; combinations are common but hypos become more likely.
What's usually done: Doses are balanced by your diabetes team; carry fast-acting glucose.
Hypo warning signs maskedMinorWith Atenolol, Bisoprolol, Carvedilol, Labetalol, Metoprolol and 3 more
Beta blockers can hide the shaking and racing heart of a low blood sugar, and non-selective ones slow recovery.
What's usually done: Check glucose more often; sweating is usually still present as a warning.
Pregnancy and breastfeeding
Generally considered safe
Insulin is the mainstay of diabetes treatment in pregnancy.
Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.
Brand names
- United States
- Lantus, Toujeo, Basaglar, Semglee
- United Kingdom
- Lantus, Toujeo, Abasaglar
- India
- Lantus, Basalog, Glaritus
- Australia
- Optisulin, Toujeo
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
History
1921
Banting and Best isolate insulin in Toronto.
1922
14-year-old Leonard Thompson becomes the first person treated.
2000
Insulin glargine approved.
Common questions
What are the signs of a low (hypo)?
Shaking, sweating, hunger, a fast heartbeat, confusion or irritability. Take 15–20 g of fast sugar (glucose tablets, juice), recheck in 15 minutes, then eat a snack.
Morning or night?
Either works — keep to the same time each day.
Do I need a prescription for Insulin glargine?
Yes — Insulin glargine is prescription-only in most countries.
Can I take Insulin glargine during pregnancy?
Generally considered safe. Insulin is the mainstay of diabetes treatment in pregnancy. Always check with a doctor or midwife.
How quickly does Insulin glargine work?
1–2 hours, no peak.
Related medicines
Insulin aspart
Fast-acting mealtime insulin.
RxInsulinsHuman insulin
The original genetically engineered insulin.
RxWHOInsulinsGlucagon
Rescue treatment for a severe hypo.
RxBlood-sugar raising agentsInsulin degludec
Ultra-long-acting basal insulin lasting over 42 hours.
RxInsulinsInsulin detemir
Long-acting insulin used to control blood sugar.
RxInsulinsInsulin lispro
Fast-acting mealtime insulin.
RxInsulins
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — A10AE04
- WHO Model List of Essential Medicines
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.